Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorColorado State University

About this trial

Bacteriophages are viruses that can selectively infect specific species and strains of bacteria. Some bacterial species in the human gut have been negatively associated with gut health and skin health. This study is designed to measure the efficacy of two different bacteriophage-based treatments for 4 weeks to improve gut and skin health. These treatments are bacteriophage that target specific strains of Escherichia coli and Staphylococcus Aureus.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Between 18-75 years old

BMI <30

Experiencing mild-moderate gastrointestinal distress/ abdominal pain, bloating, constipation, and/or diarrhea

Disqualifiers

Younger than 18 years old or greater than 75 years old

BMI >29.9

Antibiotic use in the past 2 months

Use of statins, metformin, prescription NSAIDs, and MAO inhibitors, or other medications that could interfere with study outcomes, as determined by the study PI

Trial design

Design model

Crossover

Treatments tested in this trial

  • Bacteriophages - MuniPhage

    Dietary supplement

    1 x 106 Plaque Forming Units (PFU) of bacteriophage strains PBH34, CAH57, BFX121, and DNK95

  • Bacteriophages - RenuPhage

    Dietary supplement

    1 x 106 PFU of phage strains LG91, BD117, CD007, and PD23

  • Placebo

    Other intervention

    Rice maltodextrin

Treatment groups

40 Participants
are divided into 3 treatment groups
Group A: MuniPhageExperimental treatment 1 intervention
Group B: RenuPhageExperimental treatment 1 intervention
Group C: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Gastrointestinal Symptom Rating Scale

The Gastrointestinal Symptom Rating Scale (GSRS) is a widely used tool for measuring gastrointestinal symptoms across five domains. The GSRS is scored between "No discomfort" and "Very severe discomfort"

Time frame
4 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.